1 Mar
2021
1 Mar
'21
4:40 p.m.
the executive summary really improves the report.
i wonder, if it's really necessary to delete the column with the names of the companies since this is just "raw data" which is available for everyone who does patent-research. i mean, there's no judgment or the like in it, isnt't it? Or is it also possible to get SLAPPed for that?
(few minor corrections)
best matthias
Am 25.02.2021 um 18:56 schrieb Christoph Then:
still have to work on the figures a little bit
I added a shorter executive summary (!ok?)
In the Annex, I deleted the column with the names of the companies - the most important are named in the text anyway.
Npos_2018 mailing list Npos_2018@testbiotech.de https://lists.testbiotech.de/cgi-bin/mailman/listinfo/npos_2018
--
Dr. Matthias Juhas
Gen-ethisches Netzwerk e.V. (GeN)
Stephanstraße 13
10559 Berlin
Tel. 030-685 7073
Fax: 030-684 1183
eMail: matthias.juhas@gen-ethisches-netzwerk.de
Web: www.gen-ethisches-netzwerk.de
Twitter: @GeNetzwerk